Impact of nutrition on phenotype in CFTR-deficient mice

被引:22
作者
Cottart, Charles-Henry
Bonvin, Elise
Rey, Colette
Wendum, Dominique
Bernaudin, Jean-Francois
Dumont, Sylvie
Lasnier, Elisabeth
Debray, Dominique
Clement, Annick
Housset, Chantal
Bonora, Monique
机构
[1] Hop St Antoine, INSERM, UMR S U719, Serv Anat Patol,AP HP, F-75012 Paris, France
[2] Hop St Antoine, AP HP, Serv Biochim, F-75012 Paris, France
[3] Univ Paris 06, INSERM, UMR S U680, F-75012 Paris, France
[4] Univ Paris 06, INSERM, UMR S U719, F-75012 Paris, France
[5] Univ Paris 06, EA 3499, F-75012 Paris, France
[6] Univ Paris 06, EA 3499, F-75020 Paris, France
关键词
D O I
10.1203/PDR.0b013e318155a61d
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To elucidate the impact of nutrition in cystic fibrosis (CF), we compared the phenotypic traits of Cftr(-/-) mice fed either a lipid-enriched liquid diet (Peptamen) or a standard chow combined with polyethylenglycol osmotic laxative (PEG), two strategies commonly used to prevent intestinal obstruction in CF mice. Survival, growth, liver, and ventilatory status were determined in Cftr(-/-) and Cftr(+/+) mice, followed-up until 120 d. Ventilation was recorded in conscious animals using whole-body plethysmography. We found that the survival rate was similar in Peptamen and PEG Cftr(-/-) mice. Cftr(-/-) mice had lower minute ventilation than Cftr(+/+) mice, whatever the diet. Both Cftr(-/-) and Cftr(+/+) mice fed Peptamen displayed preadult growth delay compared with PEG-treated animals. Despite subsequent growth catch-up, Cftr(-/-) mice remained smaller than Cftr(+/+) mice, whatever the diet. All Peptamen fed Cftr(-/-) mice showed hepatomegaly and liver steatosis, which also occurred but to a lesser extent in Peptamen fed Cftr(+/+) animals. Therefore, while both treatment strategies are similarly efficient to avoid high mortality at weaning, Peptamen induces preadult growth delay and liver steatosis. These effects of diet are important to consider in future animal studies and also prompt to evaluate high-energy diets in CF patients.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 30 条
[1]   CONTROL OF BREATHING IN EXPERIMENTAL ANEMIA [J].
BARTLETT, D ;
TENNEY, SM .
RESPIRATION PHYSIOLOGY, 1970, 10 (03) :384-&
[2]   Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis [J].
Beharry, Satti ;
Ackerley, Cameron ;
Corey, Mary ;
Kent, Geraldine ;
Heng, Yew-Meng ;
Christensen, Hilary ;
Luk, Catherine ;
Yantiss, Rhonda K. ;
Nasser, Imad A. ;
Zaman, Munir ;
Freedman, Steven D. ;
Durie, Peter R. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (03) :G839-G848
[3]   Ventilatory responses to hypercapnia and hypoxia in conscious cystic fibrosis knockout mice Cftr-/- [J].
Bonora, M ;
Bernaudin, JF ;
Guernier, C ;
Brahimi-Horn, MC .
PEDIATRIC RESEARCH, 2004, 55 (05) :738-746
[4]  
Clarke LL, 1996, LAB ANIM SCI, V46, P612
[5]   The "Goldilocks Effect" in Cystic Fibrosis:: identification of a lung phenotype in the cftr knockout and heterozygous mouse -: art. no. 21 [J].
Cohen, JC ;
Lundblad, LK ;
Bates, JHT ;
Levitzky, M ;
Larson, JE .
BMC GENETICS, 2004, 5 (1)
[6]   LOCALIZATION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IN HUMAN BILE-DUCT EPITHELIAL-CELLS [J].
COHN, JA ;
STRONG, TV ;
PICCIOTTO, MR ;
NAIRN, AC ;
COLLINS, FS ;
FITZ, JG .
GASTROENTEROLOGY, 1993, 105 (06) :1857-1864
[7]   ANALYSIS OF RISK-FACTORS FOR THE DEVELOPMENT OF LIVER-DISEASE ASSOCIATED WITH CYSTIC-FIBROSIS [J].
COLOMBO, C ;
APOSTOLO, MG ;
FERRARI, M ;
SEIA, M ;
GENONI, S ;
GIUNTA, A ;
SERENI, LP .
JOURNAL OF PEDIATRICS, 1994, 124 (03) :393-399
[8]   Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? [J].
Colombo, C ;
Battezzati, PM .
JOURNAL OF HEPATOLOGY, 2004, 41 (06) :1041-1044
[9]   Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients [J].
Dray-Charier, N ;
Paul, A ;
Scoazec, JY ;
Veissière, D ;
Mergey, M ;
Capeau, J ;
Soubrane, O ;
Housset, C .
HEPATOLOGY, 1999, 29 (06) :1624-1634
[10]   Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model [J].
Durie, PR ;
Kent, G ;
Phillips, MJ ;
Ackerley, CA .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1481-1493